James Krueger

James G, Krueger, MD, PhD is Head of the Laboratory for Investigative Dermatology at the Rockefeller University. He also serves as a Physician, Co-director, Center for Clinical and Translational Science at the Rockefeller University Hospital, and Chief Executive Officer of the Rockefeller University Hospital in New York City.

Dr.Krueger earned his bachelor's degree from Princeton University and a PhD in virology and cell biology from the Rockefeller University. He received an MD from Cornell University Medical College, where he also completed an internship in internal medicine and residency in dermatology. Dr.Krueger is certified by the American Board of Dermatology.

His research group at Rockefeller was the first to conduct clinical trials with specific, targeted immune antagonists in psoriasis and this work established that elimination of pathogenic T-cells from skin lesions could reverse the full pathological phenotype of psoriasis. Since then his group has used immune-based therapeutics to dissect inflammatory pathways in psoriasis and to conduct parallel pharmacogenomic studies that define mechanisms of targeted therapeutics in human populations. A more recent focus has been definition of new inflammatory pathways, as well as new types of inflammatory cells in psoriasis lesions that are now being targeted with new biologic drugs. He has been an advocate of bidirectional translational research (bench to bedside and back) in humans using psoriasis as a model inflammatory disease to dissect pathogenic pathways that cannot be studied in animal models.

Education

• A.B. in biochemistry, 1979
  Princeton University

• Ph.D., 1984
  The Rockefeller University

• M.D., 1985
  Cornell University Medical College

Awards

Distinguished Achievement Award, American Skin Association, 2001

Psoriasis Research Achievement Award, American Skin Association, 2001

E.H. Ahrens Jr. Award, Association for Patient-Oriented Research, 2006

Astellas Award, American Academy of Dermatology, 2010

Farber Award, Society of Investigative Dermatology, 2010

Van Scott Award for Innovative Therapy of the Skin, 2015